… therapeutics with potential to inhibit SARS-CoV-2 entry into … ; antivirals with potential to
block SARS-CoV-2 replication or … on the timing of the intervention with the drugs listed in this …

… (NAAT), which can detect residual SARSCoV-2 RNA for a prolonged … interventions reduces
the risk that all layers will be breached (ie, that transmission will occur). Key interventions that …

… investigational therapeutic for use in treating SARS-CoV-2 (22–24). … of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). … It may work on SARS coronavirus as well (1, 4). …

… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has … interventions might reduce
the susceptibility to SARS-CoV-2 … -pharmaceutical interventions can help to quell SARS-CoV-2 …

… to reduce mortality (such interventions would be closest to ‘… SARS-CoV-2 CHIs requires
careful review of a range of regulatory, ethical, public health, social and practical considerations, …

… acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will … of nonpharmaceutical
interventions on projected SARS-CoV-… of public health interventions on SARS-CoV-2 …

… A factor that can hinder control interventions during any epidemic is the … interventions for
different surveillance efforts (denoted f(ρ, δ) in the model), we explore the effects of interventions …

… 8 involved SARS coronavirus 1 and Middle East respiratory syndrome virus rather than
SARS-CoV-2. To extrapolate about the effectiveness of respiratory protection for SARS-CoV-2 …

… of SARS-CoV-2 is a key component of this combination approach. Multiple lines of evidence
support the effectiveness of masks for the prevention of SARS-CoV-… practical considerations. …

… Consideration #1: Study questions needing urgent answers in the acute phase of the …
SARS-CoV-2 has improved and/or when increased sample size may allow more precise answers. …